Researchers modeled the development of antibody-based treatments for Ebola virus and produced a panel of human chimeric antibodies; in vitro and rodent studies yielded an antibody cocktail that protects nonhuman primates against the related Sudan ebolavirus, which is responsible for eight outbreaks and 412 deaths since 1976.
Article #19-14985: "Development of an antibody cocktail for treatment of Sudan virus infection," by Andrew S. Herbert et al.
MEDIA CONTACT: John M. Dye, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD; e-mail: john.m.dye1.civ@mail.mil
###
Proceedings of the National Academy of Sciences